US Patent 7964607 Pyrazolo[3,4-d]pyrimidine compounds

Patent 7964607 was granted and assigned to Pfizer Limited on June, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7964607

Date of Patent

June 21, 2011

Patent Application Number

12118062

Date Filed

May 9, 2008

Patent Citations Received

‌

US Patent 12012412 Solid forms of pyrazolo[3,4-d]pyrimidine compounds

‌

US Patent 11759465 Uses

‌

US Patent 11839614 Methods for treating or mitigating cardiotoxicity characterized by inhibition of adenosine A

‌

US Patent 11919836 Prodrugs of fencamfamine

Patent Primary Examiner

‌

Susanna Moore

Patent abstract

The invention provides PDE9-inhibiting compounds of Formula (I),

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7964607 Pyrazolo[3,4-d]pyrimidine compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API